Study of KLH-2109 for uterine fibroids with heavy bleeding
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a new medicine called KLH-2109 for women who have uterine fibroids that cause heavy menstrual bleeding. The goal is to see if the medicine can reduce bleeding and improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with uterine fibroids
- You have heavy or prolonged menstrual bleeding
- You do not have other causes of abnormal bleeding, like bleeding between periods or bleeding from hormone issues
- You have not had your uterus or both ovaries removed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if relugolix can reduce heavy menstrual bleeding caused by uterine fibroids. It may be an option for women who want to avoid surgery.
This trial tests two supplements (Elix Cycle Balance and Elix Daily Harmony) to see if they can reduce pain and other symptoms caused by uterine fibroids. It is for women who have regular but painful periods and want to try a non-medicine option.
This trial tests a new device designed to safely remove uterine fibroids (benign growths in the uterus) during minimally invasive laparoscopic surgery while preserving your uterus. The goal is to see if this device makes the procedure faster and safer for women who want to keep their uterus.
This study tests how well a long-term treatment using a relugolix combination tablet helps protect bone density in women who have uterine fibroids or endometriosis. It may help people who are at risk of bone thinning while receiving hormone-related symptom treatment.
This trial tests if the drug letrozole can improve symptoms like heavy bleeding and pelvic pain caused by uterine fibroids. You must be premenopausal with moderate to severe symptoms and not have very large fibroids or certain other conditions.
This study tests a new medicine called HHK001 for endometriosis. It is compared with a standard treatment (Enantone) to see if it is safe and works well to reduce symptoms.
Hear when a new Menorrhagia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.